Top Clinical Trials companies in Belgium by Interest Coverage Ratio

This ranking features the top 4 Clinical Trials companies in Belgium ranked by Interest Coverage Ratio, averaging a Interest Coverage Ratio of -11.35, for February 06, 2025.

Belgium

Clinical Trials
Interest Coverage Ratio
#
Name
Interest Coverage Ratio
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
GLPG.AS

Galapagos NV

1

GLPG.AS
4.98
Dec. 31, 2023 USD 22.74 -0.48%

Belgium
2
MDXH

MDxHealth SA

2

MDXH
-6.69
Dec. 31, 2023 USD 1.91 0.00%

Belgium
3
SEQUA.BR

Sequana Medical NV

3

SEQUA.BR
-6.88
Dec. 31, 2023 USD 2.24 -2.03%

Belgium
4
NYXH

Nyxoah S.A.

4

NYXH
-36.82
Dec. 31, 2023 USD 10.80 2.86%

Belgium
Frequently Asked Questions
  • Which Clinical Trials company in Belgium has the highest Interest Coverage Ratio ?

    The Clinical Trials company in Belgium with the highest Interest Coverage Ratio is Galapagos NV (Amsterdam Stock Exchange: GLPG.AS) at 4.98.

  • Which Clinical Trials company in Belgium has the lowest Interest Coverage Ratio ?

    The Clinical Trials company in Belgium with the lowest Interest Coverage Ratio is Nyxoah S.A. (NasdaqGM: NYXH) at -36.82.

SV Wall Street